Will 2018 Be Johnson & Johnson's Best Year Yet?

There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A couple of major acquisitions helped the healthcare giant boost revenue to an all-time high in the third quarter.

As the new year approaches, though, investors are more focused on the future than the past. Will 2018 be Johnson & Johnson's best year yet? Probably yes. And probably no.

Image source: Getty Images.

Source: Fool.com